Matsushita, M.* ; Awazawa, M.* ; Kobayashi, N.* ; Ikushima, Y.M.* ; Soeda, K.* ; Tamura-Nakano, M.* ; Muratani, M.* ; Kobayashi, K.* ; Blüher, M. ; Brüning, J.C.* ; Ueki, K.*
An antisense transcript transcribed from Irs2 locus contributes to the pathogenesis of hepatic steatosis in insulin resistance.
Cell Chem. Bio. 29, 680-689.e6 (2022)
During insulin resistance, lipid uptake by the liver is promoted by peroxisome proliferator-activated protein (PPAR) γ upregulation, leading to hepatic steatosis. Insulin, however, does not directly regulate adipogenic gene expression in liver, and the mechanisms for its upregulation in obesity remain unclear. Here, we show that the Irs2 locus, a critical regulator of insulin actions, encodes an antisense transcript, ASIrs2, whose expression increases in obesity or after refeeding in liver, reciprocal to that of Irs2. ASIrs2 regulates hepatic Pparg expression, and its suppression ameliorates steatosis in obese mice. The human ortholog AL162497.1, whose expression is correlated with that of hepatic PPARG and the severity of non-alcoholic steatohepatitis (NASH), shows genomic organization similar to that of ASIrs2. We also identified HARS2 as a potential binding protein for ASIrs2, functioning as a regulator of Pparg. Collectively, our data reveal a functional duality of the Irs2 gene locus, where reciprocal changes of Irs2 and ASIrs2 in obesity cause insulin resistance and steatosis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Pparg ; Fatty Liver ; Insulin Resistance ; Natural Antisense Transcript ; Non-coding Rna
Keywords plus
Language
english
Publication Year
2022
Prepublished in Year
0
HGF-reported in Year
2022
ISSN (print) / ISBN
2451-9448
e-ISSN
2451-9456
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 29,
Issue: 4,
Pages: 680-689.e6
Article Number: ,
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
Cambridge, Massachusetts
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-506501-001
G-506500-001
Grants
Copyright
Erfassungsdatum
2022-05-31